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Fig. S1.  Immunofluorescence staining of CtBP1 and CtBP2 expression in MCF-7 
cells 4 d post-transfection with either control (top row) or CtBP siRNA (bottom row).  
Bar, 10 µm. 
 
 
Fig. S2.  Immunofluorescence analysis of phospho-histone H3 (red) in MCF-7 cells 4 
days post transfection with control siRNA.  DNA is stained with DAPI.  A G2 cell is 
indicated with an arrow.  The strongly staining cell is in mitosis.  Bar, 10 µm 
 
 
 Fig. S3.  Immunofluorescence analysis of CENP-A in MCF-7 cells 4 d post-
transfection with control (top row) or CtBP (middle row) siRNA. As a positive 
control for micronuclei formed from DNA damage, MCF-7 cells were radiated with 5 
Gy and fixed 48 h later (bottom row).  White arrows indicate micronuclei (DAPI, 
blue) that show positive staining for the kinetochore protein CENP-A (red) suggesting 
that they are formed from whole chromosomes.  Bar, 10 µm. 
 
 
 Fig. S4.  Structure of the Golgi apparatus in CtBP-depleted cells.  4 d post-
transfection, MCF-7 cells were immuno-stained with antibody to golgin-97 (A-21270; 
Molecular Probes).  Images of representative cells in interphase and metaphase are 
shown.  Bar, 10 µm.  White arrows indicates abnormal nuclei, demonstrating that 
Golgi structure is normal in cells in which CtBP-depletion has resulted in an abnormal 
mitotic phenotype. 
 
 
 Fig. S5.  Immunofluorescence images of MCF-7 cells 3 days post-transfection with 
control (top row) or CtBP (bottom row) siRNA, stained with antibody ab15246 
(Abcam; manufacturers instructions were used for staining with this antibody) to α-
tubulin, CtBP2 antisera, and DAPI.  There is a small amount of wavelength overlap 
from FITC (α-tubulin) in the TRITC (CtBP2) channel.  Merged images show 
localisation of α-tubulin (green) in relation to DNA (blue).  Bar, 10 µm.  Coverslips 
were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min, 
washed with PBS and incubated with ice cold methanol for 6 min.  Cells were 
permeabilised and blocked with 1% BSA/ 0.03% Triton X-100/ PBS for 30 min. 
 
 
 Fig. S6.  Monoclonal antibody E12 is specific for CtBP1, and does not recognise 
CtBP2. MCF-7 cells were transfected with a. pcDNA3.1mh vector, b. CtBP1mh or c. 
CtBP2mh, and then probed with antibodies E12 and E16. 
 
 
Fig. S7. hTERT-immortalised normal human MRC5 fibroblasts were transfected with 
either control siRNA (black bars) or CtBP siRNA (open bars) and analysed by 
western blotting for CtBP and p53 protein abundance (A, 48 h post transfection) or 
DAPI staining for frequency of cells containing micronuclei (B, 96 h post 
transfection). 
 
 
 
Fig. S8. Immunofluorescence staining of BubR1 (red) in prometaphase MCF-7 cells 4 
d post transfection with either control or CtBP siRNA.  Bar 10 µM.  Antibody 8G1 to 
BubR1 was from AbCam.  The overall pattern and intensity of staining was similar 
between control and CtBP-depleted cells, consistent with the SAC being activated in 
CtBP depleted cells throughout prometaphase. 
 
 
Fig. S9. MCF-7 cells were transfected with the indicated combinations of control, 
CtBP and p53 (Ambion siRNA ID s605) siRNA.  This p53 siRNA targets a different 
sequence in p53 than that used in Fig. 6; results obtained with the two different p53 
siRNAs were very similar.  (A) Cells were lysed for western blotting 3 days after 
transfection.  (B) Cells were analysed by live cell imaging for a 24 hour period from 
2.5 to 3.5 days post transfection.  Results from two representative fields for each 
combination of siRNAs are shown.  Combining CtBP and p53 siRNAs results in 
reduced cell numbers and increased cell death compared to individiual siRNAs 
 
 
